119 episodes
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 2 with Dr David W Cescon
22/09/2026 | 23 mins.Featuring perspectives from Dr David W Cescon, including the following topics:
Clinical treatment of BRCA-mutated metastatic triple-negative breast cancer (0:00)
CNS activity of TROP2-directed antibody-drug conjugates (5:36)
Autoimmune considerations with immunotherapy (10:09)
Treatment of oligoprogressive advanced breast cancer (17:31)
CME information and select publicationsMetastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 1 with Dr David W Cescon
21/09/2026 | 29 mins.Featuring perspectives from Dr David W Cescon, including the following topics:
First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients not eligible for immunotherapy (0:00)
First-line treatment of mTNBC in patients eligible for immunotherapy (12:05)
Adverse events (19:39)
CME information and select publicationsBreast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting
15/09/2026 | 1h 29 mins.Featuring perspectives from Dr Aditya Bardia, Dr Kevin Kalinsky and Dr Joyce O'Shaughnessy, including the following topics:
Introduction (0:00)
Hormone Receptor-Positive Breast Cancer — Dr Kalinsky (1:18)
HER2-Positive Breast Cancer — Dr Bardia (42:46)
Triple-Negative Breast Cancer — Dr O'Shaughnessy (1:01:41)
CME information and select publicationsER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists
03/09/2026 | 58 mins.Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics:
Introduction (0:00)
HER2 History (1:32)
Cases from the GMO Survey (7:06)
Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56)
Faculty Case Presentations (31:37)
Patterns of Care Survey — Part 1 (38:26)
Optimizing the Use of Up-Front Maintenance Therapy for HER2-Positive mBC — Dr Carey (44:53)
Faculty Case Presentations (54:13)
CME information and select publications- Featuring perspectives from Prof Peter Schmid and Dr Melinda Telli, including the following topics:
Introduction: TROP2-Targeting Antibody-Drug Conjugates (ADCs) for Metastatic Triple-Negative Breast Cancer (0:00)
First-Line Therapy (PD-L1 Negative) (6:53)
First-Line Therapy (PD-L1 Positive) (23:40)
Second-Line Therapy (Sequencing) (34:08)
Adverse Events with TROP2-Targeting ADCs (43:43)
CME information and select publications
More Education podcasts
Trending Education podcasts
About Breast Cancer Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
Podcast websiteListen to Breast Cancer Update, How to Be a Better Human and many other podcasts from around the world with the radio.net app

Get the free radio.net app
- Stations and podcasts to bookmark
- Stream via Wi-Fi or Bluetooth
- Supports Carplay & Android Auto
- Many other app features
Get the free radio.net app
- Stations and podcasts to bookmark
- Stream via Wi-Fi or Bluetooth
- Supports Carplay & Android Auto
- Many other app features


Breast Cancer Update
Scan code,
download the app,
start listening.
download the app,
start listening.
Breast Cancer Update: Podcasts in Family



























